We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Other Articles |

Effect of Alpha-Methyl DOPA in Severe and Malignant Hypertension

Paul J. Cannon, M.D.; Robert T. Whitlock, M.D.; R. Curtis Morris, M.D.; Marielena Angers, M.D.; John H. Laragh, M.D.
JAMA. 1962;179(9):673-681. doi:10.1001/jama.1962.03050090001001.
Text Size: A A A
Published online

A new approach to the control of arterial hypertension involving the administration of a methylated derivative of the naturally-occurring amino-acid dihydroxyphenylalanine (DOPA) has been studied in 33 patients. Alpha-methyl DOPA given orally was found to be a potent, and, in general, a smooth and well-tolerated hypotensive agent for treatment of severe and malignant hypertension. The agent seemed to have less adverse effect on renal function than other hypotensive agents. Also, the compound had no specific effect on sodium balance or aldosterone secretion. The data indicate that the compound does not interfere with endogenous norepinephrine synthesis as was thought at first. It has been suggested that alpha-methyl DOPA interferes with the activity or tissue release of norepinephrine. These results have interesting theoretical and practical implications in hypertensive vascular disease.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.